HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

BACKGROUND: The beneficial effects of early statin use in kidney transplant recipients, especially those on tacrolimus-based immunosuppression, are not well established. We evaluated the predictors of statin use following kidney transplantation and examined its association with patient and allograft...

Descripción completa

Detalles Bibliográficos
Autores principales: Younas, Nizar, Wu, Christine M, Shapiro, Ron, McCauley, Jerry, Johnston, James, Tan, Henkie, Basu, Amit, Schaefer, Heidi, Smetanka, Cynthia, Winkelmayer, Wolfgang C, Unruh, Mark
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855559/
https://www.ncbi.nlm.nih.gov/pubmed/20359353
http://dx.doi.org/10.1186/1471-2369-11-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855559/
https://www.ncbi.nlm.nih.gov/pubmed/20359353
http://dx.doi.org/10.1186/1471-2369-11-5

Ejemplares similares